Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Moderna Inc (MRNA)

Moderna Inc (MRNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 65,414,328
  • Shares Outstanding, K 384,180
  • Annual Sales, $ 18,471 M
  • Annual Income, $ 12,202 M
  • 60-Month Beta 1.65
  • Price/Sales 3.48
  • Price/Cash Flow 5.62
  • Price/Book 3.83
Trade MRNA with:

Options Overview Details

View History
  • Implied Volatility 54.56% ( +1.16%)
  • Historical Volatility 43.57%
  • IV Percentile 5%
  • IV Rank 10.98%
  • IV High 98.09% on 02/23/22
  • IV Low 49.20% on 01/20/23
  • Put/Call Vol Ratio 1.09
  • Today's Volume 33,197
  • Volume Avg (30-Day) 54,278
  • Put/Call OI Ratio 0.95
  • Today's Open Interest 349,421
  • Open Int (30-Day) 442,572

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate 4.81
  • Number of Estimates 10
  • High Estimate 6.13
  • Low Estimate 3.36
  • Prior Year 11.29
  • Growth Rate Est. (year over year) -57.40%

Price Performance

See More
Period Period Low Period High Performance
1-Month
167.28 +1.79%
on 02/01/23
207.51 -17.95%
on 01/18/23
-10.08 (-5.59%)
since 01/06/23
3-Month
155.81 +9.28%
on 11/07/22
217.25 -21.62%
on 12/14/22
+11.86 (+7.49%)
since 11/04/22
52-Week
115.03 +48.02%
on 09/29/22
217.25 -21.62%
on 12/14/22
+7.26 (+4.45%)
since 02/04/22

Most Recent Stories

More News
1 Company Bucks the Office REIT Trend With Higher Rents and Earnings

Life sciences companies may be more immune to work-from-home shifts.

ARE : 167.26 (-0.32%)
BMY : 74.53 (+0.11%)
MRNA : 170.27 (-1.72%)
LLY : 337.66 (-0.42%)
Should Invesco S&P 500 Equal Weight ETF (RSP) Be on Your Investing Radar?

Style Box ETF report for RSP

RSP : 151.98 (-0.71%)
SLB : 53.09 (+0.85%)
HAL : 38.31 (-0.67%)
MRNA : 170.27 (-1.72%)
SPY : 409.83 (-0.61%)
IVV : 411.80 (-0.62%)
3 No-Brainer Growth Stocks to Buy in 2023

These stocks all fell by double digits last year.

VRTX : 304.87 (+1.28%)
MRNA : 170.27 (-1.72%)
INMD : 36.46 (-2.09%)
CRSP : 55.51 (+0.43%)
Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, and Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines,...

PSNL : 3.88 (-0.51%)
MRNA : 170.27 (-1.72%)
Is Moderna Stock a Buy Now?

The company is starting the year on a strong note.

MRNA : 170.27 (-1.72%)
Moderna to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 23, 2023

CAMBRIDGE, MA / ACCESSWIRE / February 2, 2023 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it will host a live...

MRNA : 170.27 (-1.72%)
Moderna (MRNA) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Moderna (MRNA) closed at $174.30, marking a -1% move from the previous day.

MRNA : 170.27 (-1.72%)
Novavax Shares Jumped in January While Others Slipped

Updated FDA Covid vaccine policy could've boosted NVAX shares at the end of January, when other pharma stocks slipped, but it may not affect the bottom line.

BNTX : 140.96 (-0.77%)
NOV : 23.37 (+0.43%)
NVAX : 11.09 (-1.25%)
PFE : 43.76 (-0.68%)
MRNA : 170.27 (-1.72%)
1 Reason to Buy Novavax in 2023 and 2 Reasons to Sell

Novavax shares sank 93% last year.

MRNA : 170.27 (-1.72%)
PFE : 43.76 (-0.68%)
NVAX : 11.09 (-1.25%)
This Discount Growth Stock Is a Once-in-a-Decade Buying Opportunity Right Now

Moderna stock has dropped 60% from its peak.

MRNA : 170.27 (-1.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Moderna, Inc. is a clinical-stage pharmaceutical company, primarily focused on discovering and developing messenger RNA (mRNA) based therapies. The company's mRNA based COVID-19 vaccine, Spikevax (mRNA-1273), is approved for use in adults in the United States. The vaccine is also authorized for emergency...

See More

Key Turning Points

3rd Resistance Point 177.97
2nd Resistance Point 176.19
1st Resistance Point 173.23
Last Price 170.27
1st Support Level 168.49
2nd Support Level 166.71
3rd Support Level 163.75

See More

52-Week High 217.25
Fibonacci 61.8% 178.20
Last Price 170.27
Fibonacci 50% 166.14
Fibonacci 38.2% 154.08
52-Week Low 115.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar